Abstract:Objective To compare the efficacy and safety of prophylactic enteral probiotics administration versus placebo or no treatment in the prevention of severe NEC and sepsis in preterm infants.Methods Standard search strategy for the Cochrane Neonatal Review Group was performed by two review authors.Searches were made in PubMed,EMBASE,Ovid,Springer and CNKI databases with the terms Preterm or newborn or infants or very low birth weight or extremely low birth weight and probiotics or lactobacillus or bifidobactrium or saccharomyces and necrosis enterocolitis.Only randomized or quasi-randomized controlled trials which involved enteral administration of any live microbial supplement(probiotics) and measured at least one prespecified clinical outcome such as morbidity of severe NEC,sepsis or mortality were considered.Standard methods of the Cochrane Collaboration and its Neonatal Group were used to assess the methodological quality of the trials.RevMan 4.22 software was used to make meta analysis.Results 107 literatures were reviewed.The studies including full-term infants RCTs(n=52),reviews(n=17),commentators(n=4),documents not meeting the major results of the meta analysis(n=15),case-control studies(n=3),self-control studies(n=2),not randomized studies(n=2),data undetailed and to contact the author unsuccessfully studies(n=10) were excluded.Ten eligible trials randomizing 2 117 infants(1 056 of treatment group and 1 061 of control group) were included.The results of quality assessment were that 8 studies were A,1 was B and 1 was C.Included trials were highly variable with regard to enrollment criteria such as birth weight and gestational age,baseline risk of NEC in the control group,timing,dose,formulation of the probiotics,and feeding regimens.Data regarding extremely low birth weight(ELBW) infants were few.In a meta analysis of trial data,enteral probiotics supplementation significantly reduced the incidence of severe NEC(stage Ⅱ or above)(OR=0.34,95%CI:0.22-0.55) and mortality(OR=0.36,95% CI:0.22-0.58).There was no evidence on significant incidence reduction in nosocomial sepsis(OR=0.94,95%CI:0.62-1.42) or in NEC-related deaths(OR=0.48,95%CI:0.16-1.47).The hospilized days were longer in treatment group than that in control group(P0.01).The included trials were reported no systemic infection with the probiotics supplemental organism.Conclusions Enteral supplementation of probiotics reduced the risk of severe NEC and mortality in preterm infants.This analysis supports a change in practice in premature infants 1 000 g at birth.The safety and efficacy of administration of probiotic supplements couldn't be made in ELBW.A large randomized controlled trial is required to investigate the potential benefits and safety profile of probiotics supplementation in ELBW infants.

Reliable and fast eye finding in close-up images

Protective Effects of Bifidobacteria on Intestines in Newborn Rats with Necrotizing Enterocolitis and Its Regulation on TLR2 and TLR4.

Das Lebensmittel-Monitoring – ein wichtiges Instrument zur Erfassung und Beurteilung von unerwünschten Stoffen in und auf Lebensmitteln

Efficacy of Probiotics Versus Placebo in the Prevention of Necrotizing Enterocolitis in Preterm Very Low Birth Weight Infants: A Double-Blind Randomized Controlled Trial

A Method for Automatically Extracting Domain Semantic Networks from Wikipedia

Probiotics vs. Placebo: Preventing Necrotizing Enterocolitis in a Premature Infant

Incidence of necrotising enterocolitis before and after introducing routine prophylactic Lactobacillus and Bifidobacterium probiotics

Probiotics (Lactobacillus acidophilus and Bifidobacterium bifidum) prevent NEC in VLBW infants fed breast milk but not formula

The Effect of Oral Probiotics on the Prevention of Necrotizing Enterocolitis in Preterm Infants:A Meta-Analysis of Its Efficacy and Safety

Bifidobacterium and Lactobacillus for preventing necrotizing enterocolitis in very-low-birth-weight preterm infants: a systematic review and meta-analysis

Effect of probiotic supplementation on the gut microbiota in very preterm infants: a systematic review

The "pro" and "con" of probiotics, regulation and preterm infant health

AlAr3(THF): highly efficient reagents for cross-couplings with aryl bromides and chlorides catalyzed by the economic palladium complex of PCy3.

Probiotics for Preventing Necrotizing Enterocolitis: A Meta-Analysis with Trial Sequential Analysis

Probiotics and Human Milk Differentially Influence the Gut Microbiome and NEC Incidence in Preterm Pigs

Sex, age, height, and weight as predictors of selected physiologic outcomes.

Benefits of probiotics in preterm neonates in low-income and medium-income countries: a systematic review of randomised controlled trials

A population‐based case‐control study of human papillomavirus‐type‐16 seropositivity and incident high‐grade dysplasia of the uterine cervix

Probiotics for prevention of necrotizing enterocolitis and sepsis in preterm infants

Impact of Clinical Use of Probiotics on Preterm-Related Outcomes in Infants with Extremely Low Birth Weight

Impact of probiotics on gut microbiome of extremely preterm or extremely low birthweight infants